News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Michelon Francois Roger
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/01/2023 |
4
| Michelon Francois Roger (CEO) has filed a Form 4 on ENDRA Life Sciences Inc.
Txns:
| Granted 69,531 options
@ $4.02, valued at
$279.5k
|
|
05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/30/2022 |
4
| Michelon Francois Roger (CEO) has filed a Form 4 on ENDRA Life Sciences Inc.
Txns:
| Granted 713,132 options
@ $0.38, valued at
$271k
|
|
04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/08/2020 |
4
| Michelon Francois Roger (CEO) has filed a Form 4 on ENDRA Life Sciences Inc.
Txns:
| Sold 71,519 shares
@ $0.83, valued at
$59.4k
|
|
06/24/2020 |
4
| Michelon Francois Roger (CEO) has filed a Form 4 on ENDRA Life Sciences Inc.
Txns:
| Exercised (in-or-at-the-money) 2,874 warrants
@ $0.87, valued at
$2.5k
|
|
06/10/2020 |
4
| Michelon Francois Roger (CEO) has filed a Form 4 on ENDRA Life Sciences Inc.
Txns:
| Converted 5,175 shares
@ $0.87, valued at
$4.5k
Converted 4 convertible preferred
@ $1143.68, valued at
$5k
|
|
04/13/2020 |
4
| Michelon Francois Roger (CEO) has filed a Form 4 on ENDRA Life Sciences Inc.
Txns:
| Granted 123,064 shares
@ $0 |
|
12/11/2019 |
4
| Michelon Francois Roger (CEO) has filed a Form 4 on ENDRA Life Sciences Inc.
Txns:
| Granted 611,994 options to buy
@ $0.9, valued at
$550.8k
Granted 4 convertible preferred
@ $1143.68, valued at
$5k
Granted 5,026 warrants
@ $0.87, valued at
$4.4k
|
|
12/17/2018 |
4
| Michelon Francois Roger (CEO) has filed a Form 4 on ENDRA Life Sciences Inc.
Txns:
| Granted 125,000 options
@ $2.25, valued at
$281.3k
|
|
11/15/2018 |
4
| Michelon Francois Roger (CEO) has filed a Form 4 on ENDRA Life Sciences Inc.
Txns:
| Converted 5,953 shares
@ $1.68, valued at
$10k
Converted convertible notes
@ $1.68, valued at
$0 |
|
07/02/2018 |
4
| Michelon Francois Roger (CEO) has filed a Form 4 on ENDRA Life Sciences Inc.
Txns:
| Granted convertible notes
@ $10000, valued at
$0 Granted 2,480 warrants
@ $2.52, valued at
$6.2k
|
|
06/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|